Back
United Therapeutics Corp. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
49
UTHR
United Therapeutics Corp.
Last Price:
$480.60
Seasonality Move:
-0.46%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UTHR is experiencing slight selling pressure.
United Therapeutics Corp. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 476.97 | Sell |
| 20-day SMA: | 474.8 | Buy |
| 50-day SMA: | 485.66 | Sell |
| 200-day SMA: | 393.63 | Buy |
| 8-day EMA: | 105.79 | Buy |
| 20-day EMA: | 45.34 | Buy |
| 50-day EMA: | 18.67 | Buy |
| 200-day EMA: | 4.74 | Buy |
United Therapeutics Corp. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 37.98 | Buy |
| Relative Strength Index (14 RSI): | 48.44 | Sell |
| Chaikin Money Flow: | -49184 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (469.15 - 479.13) | Buy |
| Bollinger Bands (100): | (442.87 - 493.31) | Buy |
United Therapeutics Corp. Technical Analysis
| Feb 4 | Feb 5 | Feb 6 | Feb 9 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 17 | Feb 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for United Therapeutics Corp. Stock
Is United Therapeutics Corp. Stock a Buy?
-
United Therapeutics Corp. share price is 476.05 while UTHR 8-day simple moving average is 476.97, which is a Sell signal.
-
The stock price of UTHR is 476.05 while United Therapeutics Corp. 20-day SMA is 474.80, which makes it a Buy.
-
United Therapeutics Corp. 50-day simple moving average is 485.66 while UTHR share price is 476.05, making it a Sell technically.
-
UTHR stock price is 476.05 and United Therapeutics Corp. 200-day simple moving average is 393.63, creating a Buy signal.
UTHR Technical Analysis vs Fundamental Analysis
Sell
49
United Therapeutics Corp. (UTHR)
is a Sell
Is United Therapeutics Corp. a Buy or a Sell?
-
United Therapeutics Corp. stock is rated a SellThe current United Therapeutics Corp. [UTHR] share price is $476.05. The Score for UTHR is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
United Therapeutics Corp. Stock Info
Market Cap:
20.5B
Price in USD:
476.05
Share Volume:
218K
United Therapeutics Corp. 52-Week Range
52-Week High:
519.99
52-Week Low:
266.98
Sell
49
United Therapeutics Corp. (UTHR)
is a Sell
United Therapeutics Corp. Share Price Forecast
-
What is the United Therapeutics Corp. stock price today?The United Therapeutics Corp. stock price is 476.05 USD today.
-
Will UTHR stock go up or go down?United Therapeutics Corp.> share price is forecast to RISE/FALL based on technical indicators
-
Is United Therapeutics Corp. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, United Therapeutics Corp. is overvalued.
Is United Therapeutics Corp. Stock a Buy?
-
United Therapeutics Corp. share price is 476.05 while UTHR 8-day exponential moving average is 105.79, which is a Buy signal.
-
The stock price of UTHR is 476.05 while United Therapeutics Corp. 20-day EMA is 45.34, which makes it a Buy.
-
United Therapeutics Corp. 50-day exponential moving average is 18.67 while UTHR share price is 476.05, making it a Buy technically.
-
UTHR stock price is 476.05 and United Therapeutics Corp. 200-day simple moving average is 4.74, creating a Buy signal.
Fundamental Analysis of United Therapeutics Corp.
Is United Therapeutics Corp. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.19 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.80 per share, and an increase next year of $1.57 per share.
Technical Analysis of United Therapeutics Corp.
Should I short United Therapeutics Corp. stock?
-
UTHR Moving Average Covergence Divergence (MACD) indicator is 37.98, suggesting United Therapeutics Corp. is a Buy
-
United Therapeutics Corp. Relative Strength Index (RSI) is 48.44, which suggest United Therapeutics Corp. is oversold
-
The Bollinger Bands (25) for United Therapeutics Corp. is (469.15 - 479.13), which suggest United Therapeutics Corp. is a Buy
-
The Bollinger Bands (100) for United Therapeutics Corp. is (442.87 - 493.31), which suggest United Therapeutics Corp. is a Buy
* United Therapeutics Corp. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.